Synthesis, characterization, anticancer, and antioxidant activity of some new thiazolidin-4-ones in MCF-7 cells

dc.contributor.authorIsloor, A.M.
dc.contributor.authorDhanya, D.
dc.contributor.authorShetty, P.
dc.contributor.authorMalladi, S.
dc.contributor.authorPai, K.S.R.
dc.contributor.authorMaliyakkal, N.
dc.date.accessioned2026-02-05T09:34:53Z
dc.date.issued2013
dc.description.abstractThere are limited studies centring on the potential of thiazolidin-4-ones as anticancer agents. In this study, a new series of 2-(3-substituted-1H- pyrazol-4-yl)-3-(3-substituted-5-sulfanyl-1,2,4-triazol-4-yl)-1, 3-thiazolidin-4-one (4a-o) have been synthesized by cyclo-condensation reaction of 5-substituted-4-[(3-substituted-1H-pyrazol-4-ylmethylidene)amino]-2H-1,2,4- triazole-3-thione (3a-o) and thioglycolic acid. The structures of all the synthesized compounds were confirmed by elemental analysis, spectral techniques like IR, 1H NMR, and mass spectroscopy. Few compounds exhibited dose-dependent cytotoxic effect in MTT assay in human breast cancer (MCF-7) cells. Apoptotic degradation of DNA due to action of potent thiazolidin-4-ones was analysed by agarose gel electrophoresis and visualized by ethidium bromide staining (comet assay). A concentration-dependent increase in tail length and olive tail moment was observed when treated with thiazolidin-4-ones. In vitro antioxidant studies like DPPH and ABTS-free radical scavenging assays-indicated moderate activity of thiazolidin-4-ones. © 2012 Springer Science+Business Media, LLC.
dc.identifier.citationMedicinal Chemistry Research, 2013, 22, 2, pp. 758-767
dc.identifier.issn10542523
dc.identifier.urihttps://doi.org/10.1007/s00044-012-0071-5
dc.identifier.urihttps://idr.nitk.ac.in/handle/123456789/26832
dc.subject2 [3 (4 chlorophenyl) 1h pyrazol 4 yl] 3 [3 mercapto 5 (2 tolyloxymethyl) 4h 1,2,4 triazol 4 yl]thiazolidin 4 one
dc.subject2 [3 (4 chlorophenyl) 1h pyrazol 4 yl] 3 [3 mercapto 5 (4 tolyloxymethyl) 4h 1,2,4 triazol 4 yl]thiazolidin 4 one
dc.subject2 [3 (4 chlorophenyl) 1h pyrazol 4 yl] 3 [3 mercapto 5 (phenoxymethyl) 4h 1,2,4 triazol 4 yl]thiazolidin 4 one
dc.subject2 [3 (4 chlorophenyl) 1h pyrazol 4 yl] 3 [3 mercapto 5 [(naphthalen 1 yloxy)methyl] 4h 1,2,4 triazol 4 yl]thiazolidin 4 one
dc.subject2 [3 (4 chlorophenyl) 1h pyrazol 4 yl] 3 [3 mercapto 5 [(naphthalen 2 yloxy)] 4h 1,2,4 triazol 4 yl]thiazolidin 4 one
dc.subject2 [3 (4 fluorophenyl) 1h pyrazol 4 yl] 3 (3 mercapto 5 (2 tolyloxymethyl) 4h 1,2,4 triazol 4 yl]thiazolidin 4 one
dc.subject2 [3 (4 fluorophenyl) 1h pyrazol 4 yl] 3 (3 mercapto 5 (4 tolyloxymethyl) 4H 1,2,4 triazol 4 yl]thiazolidin 4 one
dc.subject2 [3 (4 fluorophenyl) 1h pyrazol 4 yl] 3 [3 mercapto 5 (phenoxymethyl) 4h 1,2,4 triazol 4 yl]thiazolidin 4 one
dc.subject2 [3 (4 fluorophenyl) 1h pyrazol 4 yl] 3 [3 mercapto 5 [(naphthalen 1yloxy)]methyl] 4h 1,2,4 triazol 4 yl]thiazolidin 4 one
dc.subject2 [3 (4 fluorophenyl) 1h pyrazol 4 yl] 3 [3 mercapto 5 [(naphthalen 2 yloxy)methyl] 4h 1,2,4 triazol 4 yl]thiazolidin 4 one
dc.subject3 [3 mercapto 5 (2 tolyloxymethyl) 4h 1,2,4 triazol 4 yl] 2 [3 (4 methoxyphenyl) 1h pyrazol 4 yl]thiazolidin 4 one
dc.subject3 [3 mercapto 5 (4 tolyloxymethyl) 4h 1,2,4 triazol 4 yl] 2 [3 (4 methoxyphenyl) 1h pyrazol 4 yl]thiazolidin 4 one
dc.subject3 [3 mercapto 5 (phenoxymethyl) 4h 1,2,4 triazol 4 yl] 2 [3 (4 methoxyphenyl) 1h pyrazol 4 yl]thiazolidin 4 one
dc.subject3 [3 mercapto 5 [(naphthalen 1 yloxy)methyl] 4h 1,2,4 triazol 4 yl] 2 [3 (4 methoxyphenyl) 1h pyrazol 4 yl]thiazolidin 4 one
dc.subject3 [3 mercapto 5 [(naphthalen 2 yloxy)methyl] 4h 1,2,4 triazol 4 yl] 2 [3 (4 methoxyphenyl) 1h pyrazol 4 yl]thiazolidin 4 one
dc.subjectantineoplastic agent
dc.subjectantioxidant
dc.subjectascorbic acid
dc.subjectthiazole derivative
dc.subjectunclassified drug
dc.subjectantineoplastic activity
dc.subjectantioxidant activity
dc.subjectarticle
dc.subjectbreast cancer
dc.subjectcancer cell
dc.subjectconcentration response
dc.subjectcontrolled study
dc.subjectcytotoxicity
dc.subjectDNA fragmentation
dc.subjectdrug bioavailability
dc.subjectdrug structure
dc.subjectdrug synthesis
dc.subjecthuman
dc.subjecthuman cell
dc.subjectIC 50
dc.subjectinfrared spectroscopy
dc.subjectlipophilicity
dc.subjectmass spectrometry
dc.subjectpolymerization
dc.subjectproton nuclear magnetic resonance
dc.titleSynthesis, characterization, anticancer, and antioxidant activity of some new thiazolidin-4-ones in MCF-7 cells

Files

Collections